Literature DB >> 16580084

Tumour lymphocytic infiltrate and recurrence of hepatocellular carcinoma following liver transplantation.

Esther Unitt1, Aileen Marshall, William Gelson, Simon M Rushbrook, Susan Davies, Sarah L Vowler, Lesley S Morris, Nicholas Coleman, Graeme J M Alexander.   

Abstract

BACKGROUND/AIMS: Liver transplantation is an effective treatment for highly selected patients with hepatocellular carcinoma (HCC), but tumour recurrence remains an important cause of mortality. There are few data on the relation between the recurrence of HCC and lymphocytic infiltration following liver transplantation.
METHODS: The tumour CD4+, CD8+, CD25+ and Foxp3+ lymphocyte infiltrate was assessed by immunohistochemistry in explant tissue of 69 patients who underwent liver transplantation for HCC between 1985 and 2001. The data were analysed according to HCC recurrence and factors known to be associated with outcome.
RESULTS: Tumour size (Hazard ratio (95% CI: 1.19 (1.02, 1.39), P = 0.03)), vascular invasion (P = 0.02), lymphocyte infiltration (P = 0.02) and CD4:CD8 ratio (P = 0.001) were identified as significant univariate predictors of tumour recurrence. On multivariate analysis CD4:8 ratio (P = 0.001), vascular invasion (P = 0.01), tumour size (P = 0.06) and reduced lymphocyte infiltration (P = 0.03) were significant independent predictors of recurrence. The presence of Foxp3+ T-lymphocytes was not predictive of recurrence, but was associated with vascular invasion (FE = 9.02, P = 0.04).
CONCLUSIONS: The data support the hypothesis that immune responses are important in HCC and that the phenotype of infiltrating lymphocytes is informative regarding prognosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16580084     DOI: 10.1016/j.jhep.2005.12.027

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  88 in total

1.  Cases of spontaneous tumor regression in hepatobiliary cancers: implications for immunotherapy?

Authors:  Anna L Parks; Ryan M McWhirter; Kimberley Evason; Robin K Kelley
Journal:  J Gastrointest Cancer       Date:  2015-06

Review 2.  Liver transplantation for hepatocellular carcinoma: role of inflammatory and immunological state on recurrence and prognosis.

Authors:  Matteo Cescon; Valentina Rosa Bertuzzo; Giorgio Ercolani; Matteo Ravaioli; Federica Odaldi; Antonio Daniele Pinna
Journal:  World J Gastroenterol       Date:  2013-12-28       Impact factor: 5.742

Review 3.  Prediction of hepatocellular carcinoma biological behavior in patient selection for liver transplantation.

Authors:  Umberto Cillo; Tommaso Giuliani; Marina Polacco; Luz Maria Herrero Manley; Gino Crivellari; Alessandro Vitale
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

4.  Lymphocyte-to-monocyte ratio predicts survival of patients with hepatocellular carcinoma after curative resection.

Authors:  Ze-Xiao Lin; Dan-Yun Ruan; Yang Li; Dong-Hao Wu; Xiao-Kun Ma; Jie Chen; Zhan-Hong Chen; Xing Li; Tian-Tian Wang; Qu Lin; Jing-Yun Wen; Xiang-Yuan Wu
Journal:  World J Gastroenterol       Date:  2015-10-14       Impact factor: 5.742

Review 5.  Immunological landscape and immunotherapy of hepatocellular carcinoma.

Authors:  Jesús Prieto; Ignacio Melero; Bruno Sangro
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-10-20       Impact factor: 46.802

6.  A reversed CD4/CD8 ratio of tumor-infiltrating lymphocytes and a high percentage of CD4(+)FOXP3(+) regulatory T cells are significantly associated with clinical outcome in squamous cell carcinoma of the cervix.

Authors:  Walayat Shah; Xiaofei Yan; Li Jing; Yi Zhou; Hongwei Chen; Yili Wang
Journal:  Cell Mol Immunol       Date:  2010-11-22       Impact factor: 11.530

Review 7.  T lymphocytes in hepatocellular carcinoma immune microenvironment: insights into human immunology and immunotherapy.

Authors:  Jin Bian; Jianzhen Lin; Junyu Long; Xu Yang; Xiaobo Yang; Xin Lu; Xinting Sang; Haitao Zhao
Journal:  Am J Cancer Res       Date:  2020-12-01       Impact factor: 6.166

8.  Resection or Transplant in Early Hepatocellular Carcinoma.

Authors:  Markus B Schoenberg; Julian N Bucher; Adrian Vater; Alexandr V Bazhin; Jingcheng Hao; Markus O Guba; Martin K Angele; Jens Werner; Markus Rentsch
Journal:  Dtsch Arztebl Int       Date:  2017-08-07       Impact factor: 5.594

Review 9.  The Promise of Immunotherapy in the Treatment of Hepatocellular Carcinoma.

Authors:  Anthony El-Khoueiry
Journal:  Am Soc Clin Oncol Educ Book       Date:  2017

10.  Tumor-infiltrating macrophages can predict favorable prognosis in hepatocellular carcinoma after resection.

Authors:  Yi-Wei Li; Shuang-Jian Qiu; Jia Fan; Qiang Gao; Jian Zhou; Yong-Sheng Xiao; Yang Xu; Xiao-Ying Wang; Jian Sun; Xiao-Wu Huang
Journal:  J Cancer Res Clin Oncol       Date:  2008-09-10       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.